Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 3,026–3,050 of 27,380 studies, newest first · page 122 of 1096.

October 2025 25

  1. 2025-10-01

    Impact of regional white matter hyperintensity patterns on cognitive trajectories in NACC

    ✓ Peer-reviewed Vascular contributions Alzheimer s & Dementia

    Key finding: Compared to those with low WMH burden, participants in the mild occipital and high parieto-occipital clusters had faster memory decline; mild fronto-parietal and high parieto-occipital clusters showed faster executive decline; and mild and high fronto-parietal and high parieto-occipital clusters had faster language decline. +4 more findings

  2. 2025-10-01

    Effectiveness of the In-Hospital Information Technology System-Based Delirium Management Intervention Program in Medically Hospitalized Patients with Dementia: A Retrospective Case–Control Study

    ✓ Peer-reviewed Clinical safety Journal of Multidisciplinary Healthcare

    Key finding: The intervention group showed a significantly lower delirium incidence (34% versus 18%, p =0.010) and earlier detection of delirium after hospitalization (3.2 versus 2.2 days, p =0.035). +4 more findings

  3. 2025-10-01

    Prevention of cognitive impairment and dementia in people with Parkinson's disease: A call-to-action

    ✓ Peer-reviewed Prevention trials Journal of Parkinson s Disease

    Key finding: The main pillars of a strategic agenda for this purpose include: (i) regular assessment of cognitive state, overall risk, and risk factors for cognitive decline; (ii) risk communication and education concerning modifiable risk factors with standardized procedures; (iii) risk reduction with multi-domain interventions for secondary prevention; and (iv) cognitive enhancement with cognitive and physical training for tertiary prevention.

  4. 2025-10-01

    Towards optimizing the diagnosis of Lewy body dementia: Lessons from the NACC

    ✓ Peer-reviewed Long-term cohort studies Alzheimer s & Dementia

    Key finding: Diagnosis of LBD had high specificity but low sensitivity, with fewer than half of autopsy-confirmed cases having received an LBD diagnosis. +3 more findings

  5. 2025-10-01

    Evaluating cognitive impairment among a geriatric population in India using the Indian Council of Medical Research (ICMR)–multilingual dementia research and assessment (MUDRA) toolbox

    ✓ Peer-reviewed Cognitive tests and assessment Indian Journal of Psychiatry

    Key finding: Among 1013 participants, 847 screened positive on MoCA (70.4% mild, 13.2% moderate) for cognitive impairment and were assessed further for other domains of ICMR-MUDRA toolbox. +4 more findings

  6. 2025-10-01

    Impact of cerebral small vessel disease on cognitive outcomes in early age at onset MCI and dementia: Findings from the DIASPORA study

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer s & Dementia

    Key finding: Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), Neuropsychiatric Inventory Questionnaire (NPI-Q), and Clinical Dementia Rating (CDR) scale plus National Alzheimer's Coordinating Center-Frontotemporal Lobar Degeneration module (NACC-FTLD). +4 more findings

  7. 2025-10-01

    MMSE-Based Dementia Prediction: Deep vs. Traditional Models

    ✓ Peer-reviewed Cognitive tests and assessment Life

    Key finding: These findings suggest that deep learning not only enhances predictive accuracy but also offers interpretable insights aligned with clinical reasoning, underscoring its potential utility as a reliable tool for early dementia diagnosis.

  8. 2025-10-01
  9. 2025-10-01

    GLP-1 Receptor Agonists Reduce Dementia and Alzheimer Disease Risk in Patients with Diabetes and Advanced CKD: Real-World Evidence from TriNetX

    ✓ Peer-reviewed Drug development Journal of the American Society of Nephrology

    Key finding: GLP-1RA use was associated with lower risk of dementia (HR 0.80, 95% CI 0.71–0.91) and Alzheimer’s disease (HR 0.76, 95% CI 0.59–0.98) compared to DPP4is. +4 more findings

  10. 2025-10-01
  11. 2025-10-01

    Electroencephalography‐based signatures of cognitive resilience in individuals with stable mild cognitive impairment despite carrying a high‐risk for progression to dementia

    ✓ Peer-reviewed Mild cognitive impairment Alzheimer s & Dementia Translational Research & Clinical Interventions

    Key finding: Compared with sMCI-resilient subjects, cMCI individuals exhibited increased frontal delta power, reduced posterior alpha power, and an elevated delta/alpha ratio in the right temporal region, consistent with cortical dysfunction. +4 more findings

  12. 2025-10-01

    Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study

    ✓ Peer-reviewed Mild cognitive impairment Alzheimer s & Dementia Translational Research & Clinical Interventions

    Key finding: Cox regression analysis revealed that polypharmacy was significantly associated with a reduced risk of MCI progression to dementia (hazard ratio [HR] = 0.49, 95% confidence interval [CI]: 0.31 to 0.78) after adjusting for covariates. +4 more findings

  13. 2025-10-01

    COVID-19 infection associated with increased risk of new-onset vascular dementia in adults ≥50 years

    ✓ Peer-reviewed Lewy body dementia npj Dementia

    Key finding: We observed adults aged 50 years and older from the UK Biobank over a median observational period exceeding two years following COVID-19 infection. +4 more findings

  14. 2025-10-01

    A review of studies on vascular dementia and iron metabolism

    ✓ Peer-reviewed Lewy body dementia Science Progress

    Key finding: Vascular dementia (VaD) is recognized as the second most prevalent form of dementia after Alzheimer's disease, with its pathogenesis intricately associated with cerebrovascular pathologies, including chronic hypoperfusion, oxidative stress, and neuroinflammation. +1 more finding

  15. 2025-10-01

    Plasma p‐tau217 and Aβ42/40 as markers of Aβ pathology in the Lewy body continuum

    ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia

    Key finding: Higher plasma p-tau217, lower Aβ42/40, and their interaction were associated with greater Aβ-PET uptake. +4 more findings

  16. 2025-10-01

    White matter hyperintensities precede other biomarkers in GRN frontotemporal dementia

    ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia

    Key finding: Symptomatic GRN carriers showed elevated WMHs, primarily in the frontal lobe, while no significant increase was observed in symptomatic C9orf72 or MAPT carriers. +4 more findings

  17. 2025-10-01

    Risk Factors for Dementia in a Sample of Patients From a Quaternary Care Hospital Network in the United Arab Emirates

    ✓ Peer-reviewed Risk factors Alzheimer Disease & Associated Disorders

    Key finding: A total of 281 dementia patients (mean age 74.9 ± 9.2 y, 46.3% females) and 281 age-matched controls (mean age 74.3 ± 4.6 y, 55.9% females) were included. +3 more findings

  18. 2025-10-01

    Factors associated with: problems of using exploratory multivariable regression to identify causal risk factors

    ✓ Peer-reviewed Risk factors BMJ Medicine

    Key finding: Where mutually adjusted regression coefficients are significant, the exposures are labelled as risk factors for the outcome. +3 more findings

  19. 2025-10-01

    Cardiovascular risk factors and the allostatic interoceptive network in dementia

    ✓ Peer-reviewed Risk factors Cardiovascular Research

    Key finding: We recruited 1501 participants (304 with FTLD, 512 with AD, and 685 healthy controls) from the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat). +4 more findings

  20. 2025-10-01

    Explainable and externally validated machine learning for neurocognitive diagnosis via ECGs

    ✓ Peer-reviewed Digital health tools General Psychiatry

    Key finding: Significant predictive performance was observed for several neurocognitive disorders. +4 more findings

  21. 2025-10-01
  22. 2025-10-01

    Classification of AD and bvFTD using neuropsychological and neuropsychiatric variables: a machine learning study

    ✓ Peer-reviewed Digital health tools Alzheimer s & Dementia

    Key finding: Among 1616 participants (AD = 1498, bvFTD = 118), all algorithms achieved high accuracy (80% to 90%) and discriminatory ability (AUC = 0.89 to 0.95). +4 more findings

  23. 2025-10-01

    Combined with multimodal medical imaging and artificial intelligence for early diagnosis of Parkinson's disease

    ✓ Peer-reviewed Digital health tools Frontiers in Neurology

    Key finding: Epidemiological data show that both PD incidence rate and prevalence rate show a significant age-dependent growth trend [3]. +4 more findings

  24. 2025-10-01

    Advancing early and equitable detection of dementia: key learnings/challenges, recent innovations, and future directions

    ✓ Peer-reviewed Disparities The Gerontologist

    Key finding: Systemic under-detection and its contributions to persistent population-level suffering underscore the importance of early detection of dementia as a key public health issue. +4 more findings

  25. 2025-10-01

    Population intervention models of racial ethnic disparities in cognitive outcomes from cardiometabolic risk factors – HABS-HD

    ✓ Peer-reviewed Disparities Alzheimer s Research & Therapy

    Key finding: NHB Hispanic, and NHW participants prevalences were APOE ε4 (32.2%, 27.4%, 17.6%), diabetes (26.1%, 35.0%, 13.9%), hypertension (79.0%, 63.6%, 58.2%), obesity (56.8%, 50.3%, 38.5%), and tobacco dependence (12.9%, 7.5%, 3.9%). +4 more findings

Browse the library by subject, with the full score breakdown →